I happened to be in America, and I'd read about it, and I asked my doctor in America, my physician as they like to call them, and he said, I think I can get you some. He tried me on it, and the first week or so, I was thinking, This is astonishing
Enomoto, A
PARP inhibitor protects against chronic hypoxia/reoxygenation-induced retinal injury by regulation of MAPKs, HIF1, Nrf2, and NFB
Always verify the current 503A list at the FDA's bulk drug substances page
This prevents any universal or required safety standards
for others, they are a vital, long-term tool for managing a chronic metabolic condition